Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01205776 · ClinicalTrials.gov registry record · NA
EXCEL Clinical Trial
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 1,905
- Enrollment target
NCT01205776 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,905 participants.
The verdict
NCT01205776, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,905 participants
- Enrollment target
Study Summary
To establish the safety and efficacy of the commercially approved XIENCE Family Stent System (inclusive of XIENCE PRIME, XIENCE V, XIENCE Xpedition and XIENCE PRO \[for use outside the United States \[OUS\] only\]) in subjects with unprotected left main coronary artery disease by comparing to coronary artery bypass graft surgery.
Interventions
- PROCEDURE CABG
- DEVICE Percutaneous Coronary Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,905 participants |
| Start Date | 2010-09-29 |
| Est. Completion | 2019-06-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01205776
The ClinicalTrials.gov registry entry for NCT01205776 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,905 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CABG is the first listed.
NCT01205776 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01205776 about?
NCT01205776 is a clinical study titled "EXCEL Clinical Trial". To establish the safety and efficacy of the commercially approved XIENCE Family Stent System (inclusive of XIENCE PRIME, XIENCE V, XIENCE Xpedition and XIENCE PRO \[for use outside the United States \[OUS\] only\]) in subjects with unprotected left main coronary artery disease by comparing to corona...
What is the current status of trial NCT01205776?
This trial is currently completed. It is a NA study. The enrollment target is 1,905 participants. The study started on 2010-09-29. Estimated completion is 2019-06-28.
What interventions are being tested in trial NCT01205776?
The interventions under investigation include: CABG (PROCEDURE), Percutaneous Coronary Intervention (DEVICE).
Who is sponsoring clinical trial NCT01205776?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.